Login to Your Account

Europe's advanced therapy regulations up for review

By Nuala Moran
Staff Writer

Monday, July 7, 2014
LONDON – After five years in operation, Europe's Advanced Therapy Medicinal Products (ATMP) regulation, covering therapies based on genes, cells or tissues, is up for review. The EMA last week put out a consultation paper, which is open for comment until the end of October.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription